Patents by Inventor Zelton Dave Sharp

Zelton Dave Sharp has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • USE OF MTOR INHIBITORS FOR PREVENTION OF INTESTINAL POLYP GROWTH AND CANCER
    Publication number: 20220096446
    Abstract: Disclosed are methods and compositions for the treatment or prevention of intestinal polyps or prevention of cancer in a patient who has been identified as being at risk for developing intestinal polyps or intestinal cancer. The disclosed methods and compositions include rapamycin, a rapamycin analog, or another such inhibitor of the target of rapamycin (TOR).
    Type: Application
    Filed: December 2, 2021
    Publication date: March 31, 2022
    Inventors: Zelton Dave SHARP, Randy STRONG, Paul HASTY, Carolina LIVI, Arlan RICHARDSON
  • INHIBITION OF MAMMALIAN TARGET OF RAPAMYCIN
    Publication number: 20220023230
    Abstract: Disclosed are microcapsules that include an inhibitor of the mammalian target of rapamycin (mTOR) within the microcapsules, and pharmaceutical compositions and kits that include the microcapsules. Also disclosed are methods for treating or preventing an age-related disease, condition, or disorder in a subject that involve administering to a subject a pharmaceutically effective amount of microcapsules that includes an inhibitor of mTOR within the microcapsules.
    Type: Application
    Filed: July 28, 2021
    Publication date: January 27, 2022
    Inventors: Zelton Dave Sharp, John R. Strong, Veronica Galvan, Salvatore Oddo, Herbert G. Wheeler
  • Use of mTOR inhibitors for treatment of familial adenomatous polyposis
    Patent number: 11191750
    Abstract: Disclosed are methods and compositions for the treatment or prevention of intestinal polyps or prevention of cancer in a patient who has been identified as being at risk for developing intestinal polyps or intestinal cancer. The disclosed methods and compositions include rapamycin, a rapamycin analog, or another such inhibitor of the target of rapamycin (TOR).
    Type: Grant
    Filed: June 29, 2020
    Date of Patent: December 7, 2021
    Assignee: THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
    Inventors: Zelton Dave Sharp, Randy Strong, Paul Hasty, Carolina Livi, Arlan Richardson
  • Inhibition of mammalian target of rapamycin
    Patent number: 11110067
    Abstract: Disclosed are microcapsules that include an inhibitor of the mammalian target of rapamycin (mTOR) within the microcapsules, and pharmaceutical compositions and kits that include the microcapsules. Also disclosed are methods for treating or preventing an age-related disease, condition, or disorder in a subject that involve administering to a subject a pharmaceutically effective amount of microcapsules that includes an inhibitor of mTOR within the microcapsules.
    Type: Grant
    Filed: August 27, 2019
    Date of Patent: September 7, 2021
    Assignees: The Board of Regents of the University of Texas System, Southwest Research Institute
    Inventors: Zelton Dave Sharp, John R. Strong, Veronica Galvan, Salvatore Oddo, Herbert G. Wheeler
  • USE OF MTOR INHIBITORS FOR PREVENTION OF INTESTINAL POLYP GROWTH AND CANCER
    Publication number: 20200330442
    Abstract: Disclosed are methods and compositions for the treatment or prevention of intestinal polyps or prevention of cancer in a patient who has been identified as being at risk for developing intestinal polyps or intestinal cancer. The disclosed methods and compositions include rapamycin, a rapamycin analog, or another such inhibitor of the target of rapamycin (TOR).
    Type: Application
    Filed: June 29, 2020
    Publication date: October 22, 2020
    Inventors: Zelton Dave SHARP, Randy STRONG, Paul HASTY, Carolina LIVI, Arlan RICHARDSON
  • INHIBITION OF MAMMALIAN TARGET OF RAPAMYCIN
    Publication number: 20200054576
    Abstract: Disclosed are microcapsules that include an inhibitor of the mammalian target of rapamycin (mTOR) within the microcapsules, and pharmaceutical compositions and kits that include the microcapsules. Also disclosed are methods for treating or preventing an age-related disease, condition, or disorder in a subject that involve administering to a subject a pharmaceutically effective amount of microcapsules that includes an inhibitor of mTOR within the microcapsules.
    Type: Application
    Filed: August 27, 2019
    Publication date: February 20, 2020
    Inventors: Zelton Dave Sharp, John R. Strong, Veronica Galvan, Salvatore Oddo, Herbert G. Wheeler
  • USE OF MTOR INHIBITORS FOR PREVENTION OF INTESTINAL POLYP GROWTH AND CANCER
    Publication number: 20170105974
    Abstract: Disclosed are methods and compositions for the treatment or prevention of intestinal polyps or prevention of cancer in a patient who has been identified as being at risk for developing intestinal polyps or intestinal cancer. The disclosed methods and compositions include rapamycin, a rapamycin analog, or another such inhibitor of the target of rapamycin (TOR).
    Type: Application
    Filed: October 28, 2016
    Publication date: April 20, 2017
    Inventors: Zelton Dave SHARP, Randy STRONG, Paul HASTY, Carolina LIVI, Arlan RICHARDSON
  • USE OF MTOR INHIBITORS FOR PREVENTION OF INTESTINAL POLYP GROWTH AND CANCER
    Publication number: 20160030401
    Abstract: Disclosed are methods and compositions for the treatment or prevention of intestinal polyps or prevention of cancer in a patient who has been identified as being at risk for developing intestinal polyps or intestinal cancer. The disclosed methods and compositions include rapamycin, a rapamycin analog, or another such inhibitor of the target of rapamycin (TOR).
    Type: Application
    Filed: March 13, 2014
    Publication date: February 4, 2016
    Inventors: Zelton Dave SHARP, Randy STRONG, Paul HASTY, Carolina LIVI, Arlan RICHARDSON
  • USE OF MTOR INHIBITORS FOR PREVENTION OF NEUROENDOCRINE TUMOR DEVELOPMENT AND GROWTH
    Publication number: 20160015691
    Abstract: Disclosed are methods and compositions for the prevention or inhibition of the growth of endocrine-related adenomas, neoplasia, or dysplasia in a patient who has been identified as being at risk for developing an endocrine tumor or endocrine cancer. The disclosed methods and compositions include rapamycin, a rapamycin analog, or another such inhibitor of the target of rapamycin (TOR).
    Type: Application
    Filed: March 14, 2014
    Publication date: January 21, 2016
    Inventors: Zelton Dave SHARP, Carolina LIVI, Paul HASTY, Randy STRONG
  • INHIBITION OF MAMMALIAN TARGET OF RAPAMYCIN
    Publication number: 20120064143
    Abstract: Disclosed are microcapsules that include an inhibitor of the mammalian target of rapamycin (mTOR) within the microcapsules, and pharmaceutical compositions and kits that include the microcapsules. Also disclosed are methods for treating or preventing an age-related disease, condition, or disorder in a subject that involve administering to a subject a pharmaceutically effective amount of microcapsules that includes an inhibitor of mTOR within the microcapsules.
    Type: Application
    Filed: November 11, 2009
    Publication date: March 15, 2012
    Applicant: The Board of Regents of the University of Texas System
    Inventors: Zelton Dave Sharp, John R. Strong, Veronica Galvan, Salvatore Oddo, Herbert G. Wheeler